Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
MURA
Stock Latest News
Company Announcements
Mural Oncology Plc Elects Directors at Annual Meeting
20d ago
8K
MURA
Premium
Pre-Earnings
MURA Upcoming Earnings Report: What to Expect?
2M ago
MURA
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
QID
AISP
Premium
The Fly
Unusually active option classes on open April 21st
2M ago
GE
AMC
Premium
The Fly
Mural Oncology to discontinue nemvaleukin development, reduce staff by 90%
3M ago
MURA
Premium
The Fly
Mural Oncology plans to explore strategic alternatives
3M ago
MURA
Premium
The Fly
Mural Oncology price target lowered to $6 from $18 at H.C. Wainwright
3M ago
MURA
Premium
The Fly
Mural Oncology halting progress of nemvaleukin trial in ovarian cancer
3M ago
MRK
MURA
Premium
The Fly
Mural Oncology downgraded to Hold from Buy at JonesResearch
3M ago
MURA
Premium
The Fly
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
3M ago
MURA
Premium
The Fly
Raymond James downgrades Mural Oncology after ovarian cancer failure
3M ago
MURA
Premium
The Fly
Mural Oncology downgraded to Equal Weight from Overweight at Morgan Stanley
3M ago
MURA
Premium
Ratings
Promising Developments in Mural Oncology Plc’s ARTISTRY-7 Trial Boost Buy Rating
4M ago
MURA
Premium
Ratings
Promising Outlook for Mural Oncology: Buy Rating Driven by Nemvaleukin’s Potential and Strategic Trials
4M ago
MURA
Premium
Company Announcements
Mural Oncology Highlights 2024 Financial Results and Strategic Focus
4M ago
8K
MURA
Premium
The Fly
Mural Oncology reports Q4 EPS ($2.01), consensus ($1.96)
4M ago
MURA
Premium
Ratings
Promising Prospects for Mural Oncology: Buy Rating Justified by Strong Pipeline and Financial Position
5M ago
MURA
Premium
The Fly
Mural Oncology initiated with a Buy at JonesResearch
5M ago
MURA
Premium
Company Announcements
Mural Oncology Advances Drug Pipeline and Extends Runway
6M ago
8K
MURA
Premium
Stock Analysis & Ideas
Raymond James Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
7M ago
IRON
MURA
Premium
The Fly
Mural Oncology files $300M mixed securities shelf
8M ago
MURA
Premium
The Fly
Mural Oncology reports Q3 EPS ($1.87), consensus ($1.95)
8M ago
MURA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
